Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content

Table 2 Effect of berberine chloride on hepatic ALT, AST, ALP and γGT in male mice infected with S. mansoni

From: Role of berberine in ameliorating Schistosoma mansoni-induced hepatic injury in mice

Experimental groups

ALT

AST

ALP

γ-GT

(U/g)

(U/g)

(U/g)

(U/g)

Control

304 ± 1.8

229 ± 1.8

16 ± 1

25 ± 0.8

PZQ

315 ± 1.7a

220 ± 4.5a

13 ± 0.3a

18 ± 1a

BER

318 ± 1.4a

255 ± 2.3a

7.4 ± 0.4a

15 ± 0.8a

Infected

218 ± 3.6a

125 ± 1a

36 ± 1.2a

48 ± 1.6a

Infected + PZQ

263 ± 1.3abc

146 ± 1.9 abc

17 ± 1bc

16 ± 0.5ac

Infected + BER

280 ± 2.8abc

182 ± 2.4abc

12 ± 1.6abc

20 ± 0.6abc

  1. Values are means ± SD (n = 8). aSignificant difference as compared with Group I (p ≤ 0.05). bSignificant difference as compared with corresponding control group (p ≤ 0.05). cSignificant difference as compared with infected group (Group IV) (p ≤ 0.05).